COVID - Lab leak most likely

Recent testimony from CIA highlighted the Biden Administration’s efforts to influence the COVID origin story which continues.

There is no direct evidence of the origin of COVID but there is significant and compelling scientific evidence that COVID was the result of a lab leak and that China and Fauci, for understandable reasons, and the Biden administration, for unexplainable reasons, took great efforts to obfuscate and suppress this idea.

From the lab

• Geographic and Research Coincidence: The pandemic began in Wuhan, home to the Wuhan Institute of Virology (WIV), China’s leading lab for studying SARS-like bat coronaviruses. No strong evidence of the virus circulating elsewhere beforehand, and no matching bat reservoirs locally in Wuhan.

• High-Risk Gain-of-Function Research at WIV: The lab (with U.S. collaborators via EcoHealth Alliance) conducted chimeric virus creation, passaging in humanized models, and work at BSL-2/3 levels. Documented safety concerns and incidents existed.

• DEFUSE Grant Proposal (2018): EcoHealth/WIV/Baric proposed inserting human-specific furin cleavage sites into SARS-related bat coronaviruses to study transmissibility — exactly the kind of feature that makes SARS-CoV-2 unique.

Researching work proceeds with out grants. Researchers often have done preliminary work to support their grant and/or advance their research prior to receiving grants in anticipation of grant award or alternative funding.

• Unique Furin Cleavage Site (FCS) with CGGCGG: SARS-CoV-2 has a PRRA insert (encoded by rare CGG CGG codons in coronaviruses) that enhances human infectivity. This is absent in close natural relatives and matches patterns common in lab codon-optimized constructs. DEFUSE explicitly planned such insertions.

• Sequence Obfuscation: China had extensive history and experience collecting, studying modifying coronaviruses. February 2020 China discloses RaTG13 as the closest relative (96.2% identity to SARS-CoV-2). China later discloses full sequencing occurred in 2018 (not post-outbreak as initially implied), adding to timeline discrepancies. BtCoV/4991 which is 100% identical to the corresponding region in RaTG13 was a partial sequence (370-bp RdRp fragment) published in 2016 by China from a bat fecal sample collected in 2013 in Mojiang County, Yunnan (an abandoned mine linked to a 2012 outbreak of severe pneumonia in miners, with 3 deaths). China made no mention of BtCoV/4991 when disclosing RaTG13. Normal practice is to not rename viruses as sequences are completed. The WIV’s virus database was taken offline in September 2019; raw data and full context remain limited.

• Early Indicators at WIV: Reports of WIV researchers ill with COVID-like symptoms in fall 2019 (pre-market cluster). Database deletions, shift to military oversight, and lack of transparency followed.

• Absence of Natural Intermediate Host: Despite extensive searches, no animal has been found with a virus close enough to bridge bats and SARS-CoV-2 (unlike SARS-1 or MERS). Market samples show co-location but not origin.

• Single Spillover Pattern: Genomic evidence points to one introduction event, which is atypical for wildlife market zoonoses that often involve multiple spillovers.

• Institutional and Intelligence Signals: FBI and DOE assessed lab origin with moderate confidence. 2025–2026 CIA whistleblower testimony (Erdman) described internal suppression of lab-leak analyses. Conflicts of interest in key “natural origin” papers (e.g., Proximal Origin ties to WIV/EcoHealth funding).

• Chinese Opacity as a Major Factor: Withholding of early sequences, lab records, and farm data makes natural origin harder to verify. Patterns of renaming, deletions, and non-cooperation fit protecting research-related secrets better than a distant wildlife event.

Biden/Fauci efforts to mislead

• Early Influence on “Proximal Origin” Paper (Feb 2020): Fauci and NIH Director Francis Collins organized or prompted a Feb. 1, 2020, conference call with virologists (including Kristian Andersen, Eddie Holmes, etc.) who initially expressed concerns that SARS-CoV-2 looked engineered (e.g., furin cleavage site). Within days, the group shifted to strongly favoring natural origin. The resulting Nature Medicine paper (“The Proximal Origin of SARS-CoV-2,” March 2020) was used by officials and media to label lab-leak discussions as “conspiracy theories.” Congressional probes (House Select Subcommittee) allege Fauci/Collins shaped it to downplay lab scenarios, with edits and promotion from the White House podium.

• Fauci’s Role in Intelligence Community (IC) Assessments: 2026 CIA whistleblower James E. Erdman III (Senate testimony, May 2026) alleged Fauci injected himself into IC processes, providing curated lists of conflicted SMEs (including Proximal Origin authors funded by NIAID) that influenced analyses. Multiple CIA teams (2021–2023) leaned toward lab leak (e.g., 8–9/10 in one relook), but management softened conclusions to “non-consensus” or “we may never know.” Fauci allegedly contradicted his later testimony by briefing or influencing IC. DOE and FBI moderate-confidence lab assessments were reportedly downplayed.

• Public Messaging and Labeling: Early Biden-era public health officials (including Fauci) repeatedly called lab-leak a “conspiracy theory” or fringe, despite private early doubts. This influenced media, social media censorship (in coordination with government), and scientific discourse. Fauci denied suppression in 2024 congressional testimony, stating he kept an open mind and never ruled it out.

• Declassification and Transparency Issues: Biden ordered a 90-day IC review in May 2021 (result: inconclusive). Congress passed a 2023 declassification law (signed by Biden), but whistleblowers allege the administration provided minimal/redacted info (e.g., 5 pages instead of thousands) and violated full disclosure. House probes accused HHS/Biden officials of obstruction, delays, and protecting U.S.-China research ties (e.g., EcoHealth/NIH funding).

• Broader Context and Conflicts: Critics argue efforts protected gain-of-function research funding, U.S.-China collaborations, and avoided geopolitical fallout. Fauci/Collins had stakes via NIH/EcoHealth support for WIV work. Retaliation claims against lab-leak supporters in IC and academia surfaced in probes. Natural-origin defenders say actions reflected genuine scientific consensus at the time and that no direct proof of engineering existed.

China continues to promote the natural origin idea for which, despite their exhaustive efforts, there is no direct evidence.

No identified intermediate host or progenitor: Unlike SARS-1 (civet cats clearly linked) or MERS (camels), no animal has been found with a virus close enough to SARS-CoV-2 to serve as the direct bridge. Extensive searches in wildlife, markets, and farms (including upstream suppliers to Huanan) have turned up nothing definitive after 6+ years. Market samples show virus + animal DNA (e.g., raccoon dogs), but this proves co-location/amplification, not the origin spillover site.

• Missing evolutionary intermediates: Closest relatives (RaTG13 ~96%, BANAL strains from Laos) are hundreds of miles away and lack the furin cleavage site. No clear stepwise evolution in nature has been documented. Recent 2025–2026 papers (e.g., evolutionary analyses claiming “no lab signatures”) still acknowledge this gap.

• Single introduction pattern: Genetic data point to one spillover event leading to lineages A and B. Natural zoonoses (especially in dense markets) often show multiple spillovers. This is unusual without an unsampled “perfect storm” animal reservoir.